And when combined, they often deliver the best results
It is a once-weekly medication with a long half-life of approximately five days
I wanna be really clear, I'm not trying to sell you on GLP ones
Individual responses vary considerably based on baseline gut function, diet, hydration, and dose, with some patients experiencing no significant change in bowel habits
Quick Answer: Semaglutide has been studied for over 14 years, with clinical trials beginning in the early 2010s and approximately 7 years of real-world post-marketing experience since FDA approval in December 2017
For an obesity drug at population level, thats a feature